Clinical Trial Update: Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating engineered tumor-infiltrating lymphocytes (TILs) and CAR-TILs for advanced solid tumors, sponsored by the Second Affiliated Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Breast Cancer
• Colorectal Cancer
• Hepatocellular Carcinoma
• Lung Cancer
• Solid Tumors

Drugs mentioned

• Engineered TILs / CAR-TILs (engineered tumor-infiltrating lymphocytes)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Liver Cancer, Lung Cancer | Phase 1 | Status: RECRUITING